MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free ‘PRIME’ by MangoRx, Powered by Kyzatrex^️ (a $498 value) for First 1,000 Subscribers

Dallas, Texas, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (‘GROW’) and erectile dysfunction (ED) drug (‘Mango’), is excited to announce that it is offering 2 months of free ‘PRIME’ by MangoRx, Powered by Kyzatrex^️ (“PRIME”) (a $498 value) for the first 1,000 male subscribers who express interest in subscribing to the oral testosterone replacement protocol.

Those interested in taking advantage of this exclusive offer simply need to visit the sign-up page at https://www.mangorx.com/prime-sign-up/ and submit basic demographic information. Interested subscribers will also be prompted to preorder a minimally invasive FDA approved at-home blood collection test kit through their nationwide lab partnership with Trybe Labs, which is being offered to MangoRx subscribers at preferred discounted prices.

Jacob Cohen, MangoRx’s Co-Founder and CEO, noted, “in anticipation of our official PRIME launch this month, we are excited to offer this one-time promotion to our first 1,000 interested subscribers. We are also very excited about showcasing Prime and all its amazing benefits through our marquee sponsorship with Barstool Sports for the week leading up to the Big Game in Las Vegas and for many months thereafter on the various Barstool live and streaming programs, podcasts, and events.”

Dr. Douglas Christianson, MangoRx’s advisory board member, noted, "as testosterone is a Schedule III substance, the Company has undergone additional measures - both internally and with its 3^rd party doctor’s network and pharmacy – to ensure both the safety of its customers and its compliance with all state and federal healthcare regulatory agencies. Making sure that all of these controls and safeguards are in place is paramount to MangoRx’s official launch anticipated to be later this month.”

PRIME represents a critical expansion into a new vertical with massive market potential and very little competition on the consumer side, while remaining completely consistent with MangoRx’s established identity as a company committed to providing new and innovative pharmaceutical based solutions helping men achieve optimal performance in all areas of life. With the Company’s established marketing and telemedicine infrastructure in place, MangoRx is ready to hit the ground running and take PRIME to patients in need across the country later this month. All orders will be reviewed and, pending approval, fulfilled, then discreetly shipped via MangoRx’s URAC accredited mail order partner pharmacy directly to the patient’s doorstep.